Escalon Medical (OTCMKTS:ESMC) Announces Earnings Results

Escalon Medical (OTCMKTS:ESMC) posted its quarterly earnings results on Tuesday. The medical equipment provider reported $0.12 EPS for the quarter, Zacks reports. Escalon Medical had a negative return on equity of 21.42% and a net margin of 16.17%.

Escalon Medical Stock Performance

Shares of ESMC traded up $0.01 during mid-day trading on Tuesday, reaching $0.17. The company’s stock had a trading volume of 30,060 shares, compared to its average volume of 19,084. The company has a current ratio of 2.59, a quick ratio of 1.94 and a debt-to-equity ratio of 0.04. Escalon Medical has a 1-year low of $0.14 and a 1-year high of $0.28. The business has a 50-day simple moving average of $0.17 and a two-hundred day simple moving average of $0.18. The stock has a market cap of $1.22 million, a P/E ratio of 1.50 and a beta of 0.51.

About Escalon Medical

Escalon Medical Corp. is a medical-device company focused on products for the ophthalmic surgical market. The company develops, manufactures and markets devices and related products used by eye-care professionals, particularly in procedures involving the retina and vitreous.

Its product offerings have included ophthalmic surgical instruments, delivery systems and products used in retinal surgery, such as intraocular gases, silicone oils and other retinal tamponade materials. These products are designed to support procedures for treating retinal detachments and other serious eye conditions.

Escalon Medical has historically served ophthalmic surgeons and medical institutions through markets in the United States and internationally.